1. Home
  2. Analysis
  3. Pegasys
  4. Lip-disorder

Pegasys and Lip disorder - a phase IV clinical study of FDA data

Summary:

Lip disorder is reported as a side effect among people who take Pegasys (peginterferon alfa 2a), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Copegus, and have Abdominal discomfort.

The phase IV clinical study analyzes which people have Lip disorder when taking Pegasys. It is created by eHealthMe based on reports of 57,338 people who have side effects when taking Pegasys from the FDA, and is updated regularly.

What is Pegasys?

Pegasys has active ingredients of peginterferon alfa 2a. It is often used in hepatitis c. eHealthMe is studying from 57,446 Pegasys users. Check the latest studies of Pegasys.

What is Lip disorder?

Lip disorder (disease of lip) is found to be associated with 296 drugs and 404 conditions by eHealthMe. Check the latest studies of Lip disorder.

On Jul, 10, 2026

57,338 people reported to have side effects when taking Pegasys.
Among them, 13 people (0.02%) have Lip disorder.

Could Pegasys cause Lip disorder?

Among these 13 people:

How long have people been on Pegasys when they have Lip disorder? *

  • < 1 month: 33.33 %
  • 1 - 6 months: 66.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Lip disorder when taking Pegasys? *

  • female: 69.23 %
  • male: 30.77 %

What is the age of people who have Lip disorder when taking Pegasys? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 10 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 40 %
  • 50-59: 30 %
  • 60+: 20 %

What are other drugs people take besides Pegasys? *

  1. Copegus: 5 people, 38.46%
  2. Incivek: 4 people, 30.77%
  3. Ribavirin: 3 people, 23.08%
  4. Sovaldi: 2 people, 15.38%
  5. Victrelis: 1 person, 7.69%
  6. Tramadol: 1 person, 7.69%
  7. Miralax: 1 person, 7.69%
  8. Meloxicam: 1 person, 7.69%
  9. Lexapro: 1 person, 7.69%
  10. Benadryl: 1 person, 7.69%

What are other side effects people have besides Lip disorder? *

  1. Nausea (feeling of having an urge to vomit): 6 people, 46.15%
  2. Weight Decreased: 4 people, 30.77%
  3. Itching: 4 people, 30.77%
  4. Taste - Impaired: 4 people, 30.77%
  5. Nausea And Vomiting: 4 people, 30.77%
  6. Pain: 4 people, 30.77%
  7. White Blood Cell Count Decreased: 3 people, 23.08%
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 3 people, 23.08%
  9. Headache (pain in head): 3 people, 23.08%
  10. Insomnia (sleeplessness): 3 people, 23.08%

What are the existing conditions these people have? *

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 7.69%
  2. Sinus Congestion (blockage of sinus): 1 person, 7.69%
  3. Pain: 1 person, 7.69%
  4. High Blood Pressure: 1 person, 7.69%
  5. Depression: 1 person, 7.69%
  6. Abdominal Discomfort: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pegasys and have Lip disorder?

- Check whether Lip disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pegasys:

Lip disorder treatments and more:

How severe was Lip disorder and when was it recovered:

Expand to all the drugs that have ingredients of peginterferon alfa 2a:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pegasys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lip disorder:

Browse all the conditions that are associated with Lip disorder:

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon alfa 2a (the active ingredients of Pegasys) and Pegasys (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.